Drugs

, Volume 64, Issue 6, pp 630–630 | Cite as

Is Omapatrilat a Novel Therapy of the Past Rather Than the Future?

  • Tsung O. Cheng
Correspondence
  • 19 Downloads

Keywords

Cardiol Enalapril Endopeptidase Cardiovascular Disorder Death Sentence 

References

  1. 1.
    Tabrizchi R. Dual ACE and neutral endopeptidase inhibitors: novel therapy for patients with cardiovascular disorders. Drugs 2003; 63(20): 2185–202PubMedCrossRefGoogle Scholar
  2. 2.
    Cheng TO. Omapatrilat May Indeed NOt be mUch Superior (OMINOUS) [letter]. Int J Cardiol 2003; 91: 113PubMedCrossRefGoogle Scholar
  3. 3.
    Coats AJ. Omapatrilat: the story of Overture and Octave. Int J Cardiol 2002; 86: 1–4PubMedCrossRefGoogle Scholar
  4. 4.
    Cheng TO, Julian D. Acronyms of cardiologic trials: 2002. Int J Cardiol 2003; 91: 261–351PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  • Tsung O. Cheng
    • 1
  1. 1.George Washington University Medical CenterWashingtonUSA

Personalised recommendations